Apollo Hospitals Unveils New Brain Tumour Treatment

Non-invasive, 30-Minute Sessions Offer Faster Recovery and Improved Patient Comfort, Zap-X brings precise targeting safety to transform patient outcomes. The ZAP-X Gyroscopic Radiosurgery Platform, a revolutionary advancement in brain tumour treatment, marking a significant milestone as the first in South Asia to introduce this ground-breaking technology. With ZAP-X, Apollo Hospitals continues its legacy of innovation and commitment to providing world-class healthcare solutions for patients in India and across the world. This transformative technology redefines precision with minimal radiation exposure, enabling new standards in effectiveness and patient comfort. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design, to direct radio-surgical beams from thousands of potential angles, accurately focusing radiation on the intended tumour or target.

Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group said at the launch: “For more than four decades, Apollo Hospitals has been at the forefront of healthcare, continuously challenging limits to provide exceptional care. Upholding this tradition, we have unveiled ZAP-X, an innovative   technology designed for the treatment of brain tumours. Furthermore, as an outpatient procedure it allows for greater convenience and accessibility for patients. We commit to ensure that this technology is made available for every citizen of our country and for people across geographies, as this will be a boon for how brain tumours are approached and treated.”

Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine said, “Stereotactic radiosurgery is among the most important medical advancements of the past century. Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.”

Leave a Reply

Your email address will not be published. Required fields are marked *